Merck CDR Valuation
| MRK Stock | 26.96 0.79 2.85% |
At this time, the firm appears to be undervalued. Merck CDR secures a last-minute Real Value of USD30.29 per share. The latest price of the firm is USD26.96. Our model forecasts the value of Merck CDR from analyzing the firm fundamentals such as Revenue of 65.01 B, price to book of 5.84 X, and Return On Equity of 39.51 as well as examining its technical indicators and probability of bankruptcy.
Price Book 5.84 | Enterprise Value 436.7 B | Enterprise Value Ebitda 14.4418 | Price Sales 4.7046 | Forward PE 24.2131 |
Undervalued
Today
Please note that Merck CDR's price fluctuation is very steady at this time. Calculation of the real value of Merck CDR is based on 3 months time horizon. Increasing Merck CDR's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Merck CDR is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Merck Stock. However, Merck CDR's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 26.96 | Real 30.29 | Hype 26.96 | Naive 26.12 |
The intrinsic value of Merck CDR's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Merck CDR's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Merck CDR helps investors to forecast how Merck stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Merck CDR more accurately as focusing exclusively on Merck CDR's fundamentals will not take into account other important factors: About Merck CDR Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Merck CDR. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Merck CDR based exclusively on its fundamental and basic technical indicators. By analyzing Merck CDR's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Merck CDR's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Merck CDR. We calculate exposure to Merck CDR's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Merck CDR's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 53 B | 51.9 B |
Merck CDR Quarterly Retained Earnings |
|
Other Information on Investing in Merck Stock
Merck CDR financial ratios help investors to determine whether Merck Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Merck with respect to the benefits of owning Merck CDR security.